Yahui Ding

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background: The poor outcomes for patients diagnosed with acute myeloid leukemia (AML) are largely attributed to leukemia stem cells (LSCs) which are difficult to eliminate with conventional therapy and responsible for relapse. Thus, new therapeutic strategies which could selectively target LSCs in clinical leukemia treatment and avoid drug resistance are(More)
Given the capacity of self-renewal and multilineage differentiation, stem cells are promising sources for use in regenerative medicines as well as in the clinical treatment of certain hematological malignancies and degenerative diseases. Complex networks of cellular signaling pathways largely determine stem cell fate and function. Small molecules that(More)
In order to improve the accuracy of recognizing human action, a human action recognition model is proposed based on improved convolutional neural networks. Most of the current methods build classifiers based on complex handcrafted features computed from the raw inputs. Convolutional neural network (CNN) is a type of deep model that can act directly on the(More)
Hematopoietic stem cells (HSCs) have emerged as promising therapeutic cell sources for high-risk hematological malignancies and immune disorders. However, their clinical use is limited by the inability to expand these cells ex vivo. Therefore, there is an urgent need to identify specific targets and effective probes that can expand HSCs. Here we report a(More)
  • 1